Multiple Sclerosis Clinical Trial
Official title:
Investigation of the Effects of Local Vibration Applied to Different Regions and Spinal Stabilization Exercises on Postural Control in Patients With Ataxic Multiple Sclerosis
The aim of this study is to investigate the effects of local vibration application applied to different regions on postural control in addition to spinal stabilization training in ataxic multiple sclerosis (MS) patients. The study was planned as a single-blind, randomized controlled trial. The patients included in the study will be divided into 3 groups by the closed-envelope randomization method. Each treatment will be 8 weeks, 3 days a week. The control group will be given 40 minutes of lumbar spinal stabilization exercises. Paraspinal vibration group; In addition to 40 minutes of lumbar spinal stabilization exercises, LV will be applied to the paraspinal muscles for 10 minutes. LV application will be applied to the cervical paraspinal muscles for 5 minutes and to the lumbar paraspinal muscles for 5 minutes, bilaterally, sequentially. Gastrosoleus vibration group; In addition to 40 minutes of lumbar spinal stabilization exercises, LV will be applied to the gastrosoleus muscle complex for 10 minutes. LV application will be applied bilaterally, sequentially (5 minutes on the right and left). Assessments will be made by a blind assessor. In assessments; demographic information, Expanded Disability Status Scale (EDSS) /Extended Disability Status Scale (disease stage), International Cooperative Ataxia Rating Scale (ataxia severity), Berg Balance Scale (performance-based balance), Trunk Impairment Scale (trunk control), Neurocom Balance Master Static Posturography (limits of stability and postural sway), OptoGait (gait analysis), lumbopelvic muscle endurance tests will be used.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | August 1, 2024 |
Est. primary completion date | June 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility | Inclusion Criteria: - Being between the ages of 18-50 - Having been diagnosed with MS by a neurologist - EDSS score between 3-5 - EDSS pyramidal system score of 3 or less - Not using corticosteroids and/or stopping at least 3 months before starting the study Exclusion Criteria: - Having a history of attacks in the last 3 months - Having orthopedic or systemic problems - Presence of peripheral vestibular complaints - Participating in another exercise program in the last 6 months - Being mentally affected (Mini-Mental Test Score < 24) - Severe spasticity (MAS>3) - Refusal to participate in the study |
Country | Name | City | State |
---|---|---|---|
Turkey | Hacettepe University Faculty of Health Sciences Department of Physical Therapy and Rehabilitation | Ankara |
Lead Sponsor | Collaborator |
---|---|
Hacettepe University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Expanded Disability Status Scale | Being between Expanded Disability Status Scale 3-5 and having a pyramidal system score below 3 are among the inclusion criteria. At the beginning of the study, all patients will be evaluated for Expanded Disability Status Scale, and patients who do not meet the criteria will not be included in the study.An increase in the score indicates an increase in the severity of the disease. | Assessment will be done before treatment starts ( on average 15 minutes takes). | |
Primary | International Cooperative Ataxia Rating Scale | It will be used to evaluate the severity of ataxia. International Cooperative Ataxia Rating Scale consists of 4 sub-titles: posture and gait disorders, kinetic functions, speech disorders and oculomotor disorders. The score range is in the range of 0-100, with an increase in the score indicating increased disease severity. | Change from International Cooperative Ataxia Rating Scale at 8 weeks (each assessment on average 20 minutes takes). | |
Primary | Berg Balance Scale | BBS is a scale that evaluates performance-based balance and scores the performance of 14 different tasks from 0 (not applicable) to 4 (normal performance). In this scale, which is evaluated over 56 points; scores between 0-20 indicate balance disorder, between 21-40 the balance is acceptable, and scores between 41-56 indicate good balance. | Change from Berg Balance Scale at 8 weeks (each assessment on average 20 minutes takes). | |
Primary | Trunk Impairment Scale | The Trunk Impairment Scale, which will be used to evaluate trunk control, has a total of 17 items, of which 3 are static balance, 10 are dynamic balance, and 4 are the coordination ability of the stabilizer muscles. The total score of 0-23 points is recorded. A high score indicates good trunk control. | Change from Trunk Impairment Scale at 8 weeks (each assessment on average 10 minutes takes). | |
Primary | Limits of Stability and Postural Sways | It will be evaluated with Neurocom Balance Master Static Posturography. During the test, the patient is asked to stand on the platform without shoes and socks. The upper extremities are asked to be on the side of the trunk without support and to look forward. Limits of stability are evaluated with eyes open on a firm surface. While the feet are on the force platform, the foot contact is maintained and the person is asked to go in 8 directions (forward, right-forward, right, right-back, back, left-back, left, left-forward) without losing balance. The test is finished when all directions are completed. Postural sway is evaluated in 4 situations; eyes open-firm surface, eyes closed-firm surface, eyes open-foam surface, eyes closed-foam surface. The person is asked to be as stable as possible. | Change from limits of stability and postural sways at 8 weeks (each assessment on average 15 minutesutes takes). | |
Primary | Gait Analysis | OptoGait Gait Device (Microgate, Bolzano, Italy).Timing, size, and distance are detected and time-distance characteristics are calculated automatically when patients pass between 2 bars positioned on either side of the treadmill. During the test, the patient is asked to get on the treadmill. Then the patient is asked to adjust the speed of the treadmill according to himself (at the speed he feels comfortable) and walk for 1 minute. When the patient walks on the treadmill, objective data about the time-distance characteristics of his gait are obtained. Gait velocity will be recorded in meters/second. Cadence will be recorded in steps/minute.The stride length will be recorded in centimeters.The stance phase and swing phase will be recorded in percent (%). | Change from gait 8 weeks (each assessment on average 5 minutes takes). | |
Primary | Prone Bridge Test | Test will be used to evaluate the endurance of lumbopelvic muscles.The patients placed elbows and forearms below their shoulders, straightened the legs. Next, they kept their forearms and toes on the floor, lifted hips, and maintained this straight position as long as possible. | Change from lumbopelvic muscle endurance at 8 weeks . In the test, how many seconds they stop is tested. | |
Primary | Lateral Bridge Test | Test will be used to evaluate the endurance of lumbopelvic muscles. The patients lay on their left / right sides with support from the forearm with elbows below the shoulders and extended their legs straight. Then the patients lifted their hip from the floor. The test was terminated when the side bridge position deteriorated or the hip fell. | Change from lumbopelvic muscle endurance at 8 weeks . In the test, how many seconds they stop is tested. | |
Primary | Sorensen Test (Trunk Extensor Test) | Test will be used to evaluate the endurance of lumbopelvic muscles. The patients lied down on a treatment table, aligning their anterior superior iliac spine with the edge of the table, which allowed the upper body to be planked out over the edge. An assessor fixed the patients' pelvis, hip, and knees to the treatment table. The body and the upper extremities were supported using a chair. Next, the chair was removed, and the patients maintained the horizontal body position as long as possible with their arms crossed position on the chest. | Change from lumbopelvic muscle endurance at 8 weeks . In the test, how many seconds they stop is tested. | |
Primary | Trunk Flexors Test | Test will be used to evaluate the endurance of lumbopelvic muscles. The patients were in a sit-up position while their trunks were supported at the angle of 60 degrees from the floor. They flexed knees and hips at 90 degrees and crossed arms over the chest. Then, the support of the trunk was removed, and the patients maintained this position as long as possible. | Change from lumbopelvic muscle endurance at 8 weeks . In the test, how many seconds they stop is tested. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |